GLYCOREX TRANSPLANTATION

glycorex-transplantation-logo

Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ยฎ -ABO, enables transplants across the blood group boundaries. This product has been used clinically since the fall of 2001 and enabled more than 3,500 blood group incompatible transplants with excellent clinical results. The company also develops products within universal blood plasma and products for specific treatment of autoimmune diseases, specifically Myasthenia gravis.

#SimilarOrganizations #People #Website #More

GLYCOREX TRANSPLANTATION

Social Links:

Industry:
Biotechnology Clinical Trials Health Care Manufacturing Medical Pharmaceutical

Founded:
1996-01-01

Address:
Lund, Skane Lan, Sweden

Country:
Sweden

Website Url:
http://www.glycorex.se

Total Employee:
11+

Status:
Active

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Cision


Similar Organizations

body-surface-translations-logo

Body Surface Translations

Body Surface Translations is a biomedical device company.

promedim-logo

Promedim

Promedim is advanced cloud-based technology, integrated control centre.

Current Employees Featured

not_available_image

Kurt Nilsson
Kurt Nilsson Founder @ Glycorex Transplantation
Founder

johan-nilsson_image

Johan Nilsson
Johan Nilsson CEO @ Glycorex Transplantation
CEO
2013-09-01

Founder


not_available_image

Kurt Nilsson

Official Site Inspections

http://www.glycorex.se

  • Host name: akilles.oderland.com
  • IP address: 91.201.60.23
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Loading ...

More informations about "Glycorex Transplantation"

Board of Directors and CEO - Glycorex Transplantation โ€ฆ

Mar 29, 2021 Background and education: Founder and former CEO and Development and Product Manager at Glycorex Transplantation AB. Currently โ€ฆSee details»

Contact - Glycorex Transplantation AB

Mar 29, 2021 +46 46 286 52 30 [email protected]. About Glycorex. Market strategy; Investors. Financial reports; The Share โ€“ information; Presentations; Corporate Governance; Board of โ€ฆSee details»

Glycorex Transplantation - Crunchbase Company โ€ฆ

Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ® -ABO, โ€ฆSee details»

Glycorex Transplantation AB (publ) | LinkedIn - LinkedIn Sverige

Glycorex Transplantation AB (publ) | 970 följare på LinkedIn. Optimizing blood for life โ€“ solutions for improved quality of life and better health economy | Glycorex Transplantation AB (publ) is a โ€ฆSee details»

Glycorex AB - A Company At Ideon - Ideon Science Park

Glycorex AB. Address. Scheelevägen 27, 223 70 Lund. Building. Gateway. Company website. www.glycorex.se. Phone. 046-286 5230. E-mail. [email protected]. About Ideon. โ€ฆSee details»

Glycorex Transplantation AB | Ideon Science Park

Glycorex Transplantation AB (publ) is a medical technology company involved in development, production and sales in the fields of organ transplantation and ...See details»

Glycorex Transplantation AB | Nordic Growth Market - ngm.se

Glycorex Transplantation is a biotechnology company. Currently, the company conducts research, development and marketing within the field of organ transplantation. The main product of the โ€ฆSee details»

Glycorex Transplantation Company Profile - Office Locations ...

Glycorex Transplantation kr36.12 m in annual revenue in FY 2022. See insights on Glycorex Transplantation including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

About Glycorex - Glycorex Transplantation AB

Glycorex has recently launched a new product version designed to be used for donated plasma to produce universal blood plasma that can be given regardless of the recipientโ€™s blood group, โ€ฆSee details»

Glycorex strengthens the organization to place additional force โ€ฆ

Jan 31, 2023 On December 8, 2022, Johan Lavén took over as the new CEO of Glycorex with the task of implementing the company's growth strategy by expanding the company's โ€ฆSee details»

Glycorex Transplantation - placera.se

Dec 21, 2021 E-mail: [email protected], phone: 046-286 52 30 Brief information about the company Glycosorb® ABO is one of Glycorex Transplantation AB's self-developed proprietary โ€ฆSee details»

Glycorex Transplantation - placera.se

Nov 2, 2021 Johan Nilsson, Interim CEO, Glycorex Transplantation AB. E-mail: [email protected], phone: 046-286 52 30. This information is such information that Glycorex โ€ฆSee details»

Glycorex strengthens the organization to place additional force โ€ฆ

The organization is now fully focused on delivering on our Going 4 Growth strategy that holds great growth opportunities in a number of areas, short-term as well as long-term. To add โ€ฆSee details»

Glycorex Transplantation

Mar 9, 2023 Johan Lavén, CEO Glycorex Transplantation AB Email: [email protected] Tel: + 46 (0)73 330 92 16. Brief information about the company. Glycorex Transplantation AB โ€ฆSee details»

Enabling transplants across blood groups is no longer science fiction

CEO Geert Nygaard joined Glycorex in December 2021. Since then, he has worked together with his team to define the way forward for the company. In this interview, Geert talks about โ€ฆSee details»

Glycorex Transplantation: Manufacturing of low titer-blood

Glycorex Transplantation AB (publ.), listed on NGM Main Regulated Equity, announces that the Transfusion unit at the University of Rochester Medical Center presents their experience with โ€ฆSee details»

Financial reports - Glycorex Transplantation AB

+46 46 286 52 30 [email protected]. About Glycorex. Market strategy; Investors. Financial reports; The Share โ€“ information; Presentations; Corporate Governance; Board of Directors โ€ฆSee details»

Glycorex ökar omsättningen och minskar förlusten - Dagens industri

3 days ago Medicinteknikbolaget Glycorex hade ett rörelseresultat om -3,0 miljoner kronor under det tredje kvartalet (-5,4). Nettoomsättningen uppgick till 7,4 miljoner kronor (6,2). ... org.nr: โ€ฆSee details»

Glycorex strengthens the organization to place additional force โ€ฆ

Jan 31, 2023 On December 8, 2022, Johan Lavén took over as the new CEO of Glycorex with the task of implementing the company's growth strategy by expanding the company's โ€ฆSee details»

linkstock.net © 2022. All rights reserved